DiGeorge syndrome
![](/Images/godic/202502/19/Brain_computer_tomography_cuts_of_the_patient_with_22q11.2_syndrome,_demonstrating_basal_ganglia_and_periventricular_calcification2224.jpg")
![22q11.2 deletion syndrome is inherited in an autosomal dominant pattern.](/Images/godic/202502/19/Autosomal_dominant_-_en.svg2225.png")
![Result of FISH analysis using LSI probe (TUPLE 1) from DiGeorge/velocardiofacial syndrome critical region. TUPLE 1 (HIRA) probe was labeled in Spectrum Orange and Arylsulfatase A (ARSA) in Spectrum Green as control. Absence of the orange signal indicates deletion of the TUPLE 1 locus at 22q11.2.](/Images/godic/202502/19/Fish_analysis_di_george_syndrome2225.jpg")
DiGeorge syndrome is also known as 22q11.2 deletion syndrome, DiGeorge anomaly, velocardiofacial syndrome (VCFS), Shprintzen syndrome, conotruncal anomaly face syndrome (CTAF) or Takao syndrome, Sedlackova syndrome, Cayler cardiofacial syndrome, Strong syndrome, congenital thymic aplasia, and thymic hypoplasia. This syndrome is caused by the deletion of a small piece of chromosome 22. As such, it is recommended that the name "22q11.2 deletion syndrome (22q11.2DS)" be used.